Tianjin TEDA Pharmaceutical

Tianjin TEDA Pharmaceutical, often operating under the umbrella of Tianjin TEDA Biomedical Engineering Co., Ltd., is a Chinese pharmaceutical company focused on the research, development, and commercialization of biological compounds and traditional Chinese medicine-derived therapies. The company is well-known for its production of Compound Glycyrrhizin tablets, which are widely used in the treatment of chronic liver diseases and dermatological conditions. Beyond hepatology, the firm maintains a presence in the medical devices sector and the health food industry, leveraging its location in the Tianjin Economic-Technological Development Area (TEDA). Its business model integrates manufacturing with a robust distribution network across mainland China, targeting both chronic disease management and general wellness.